Skip to content

Influence of the solution used for the long dwell on the results of the Peritoneal Equilibration Test using 3.86% glucose in CAPD.

Influence of the solution used for the long dwell on the results of the Peritoneal Equilibration Test using 3.86% glucose in CAPD. - Ico-PET

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON35502
Enrollment
20
Registered
2009-10-19
Start date
2009-11-01
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

peritoneal dialysis peritoneal equilibration test

Interventions

None listed

Sponsors

Interne Geneeskunde - Onderafdeling Nefrologie
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: stable CAPD patients > 18 years old peritonitis-free for at least 6 weeks before and between both PETs able to give informent consent

Exclusion criteria

Exclusion criteria: peritonitis less than 6 weeks before or between the PETs Allergy of icodextrin

Design outcomes

Primary

MeasureTime frame
The following parameters will be assessed: - Standardized 3.86% glucose PET preceded by a night dwell (8 to 12 hours) with a 3.86% glucose solution - Standardized 3.86% glucose PET preceded by a night dwell (8 to 12 hours) with glucose polymer solution (Icodextrin) - Standardized 3.86% glucose PET preceded by a night dwell (8 to 12 hours) with a 2.27% glucose solution The main outcome parameter will be D0/Dt of glucose. Do is the glucose concentration in the dialysate at start and Dt is the glucose concentration in the dialysate after 60 and 240 minutes.

Secondary

MeasureTime frame
The following laboratory parameters will be assessed: - Serum: glucose, urea, creatinine, sodium, albumin - Dialysate fluid: glucose, urea, creatinine, phosphate, sodium, albumin (of de preceding night dwell and during the PET at start, after 60 and 240 min)

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)